Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

______________________

 FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  April 17, 2019
 
ASPEN TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
001-34630

 
04-2739697
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
20 Crosby Drive, Bedford, MA
 
01730
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (781) 221-6400
 
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
 


 






Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)
On April 17, 2019, the board of directors elected Georgia Keresty as one of our Class III directors effective immediately. Her term will expire at the 2020 Annual Meeting of Stockholders. She was also appointed to serve on the Audit Committee, Compensation Committee, and the Nominating and Corporate Governance Committee of our board of directors.
Upon her election to the board, Ms. Keresty was granted 887 Restricted Stock Units and an option to acquire 1,684 shares of our common stock. She will receive cash compensation in accordance with our director compensation policy as described in the company’s definitive proxy statement on Schedule 14A filed on October 26, 2018.
Ms. Keresty is currently the Takeda R&D chief operating officer. On April 18, 2019, we issued a press release announcing her election to our board of directors. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 
Item 9.01                                             Financial Statements and Exhibits.
 
(d)                                 Exhibits.
 
The following exhibit is filed as part of this report:
 
Exhibit No.
 
Description
 
 
 
99.1
 




































SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
ASPEN TECHNOLOGY, INC.
 
 
 
 
 
 Date: April 18, 2019
By:
/s/ Frederic G. Hammond
 
 
Frederic G. Hammond
 
 
Senior Vice President and General Counsel
 



































Exhibit


Exhibit 99.1
Contact:     
Aspen Technology, Inc.
 Lucy Millington
 Aspen Technology
 Lucy.millington@aspentech.com

Aspen Technology Appoints Georgia Keresty PhD, MPH to Its Board of Directors
 
Keresty brings extensive operational and leadership expertise in the pharmaceutical industry to Aspen Technology

BEDFORD, Mass. - April 18, 2019 - Aspen Technology, Inc. (NASDAQ: AZPN), the asset optimization™ software company, today announced that Georgia Keresty has been appointed to the Aspen Technology board of directors.

Keresty brings more than 35 years of experience within the highly regulated pharmaceutical and healthcare industry where she has built a strong reputation as a scientific leader who drives operational excellence and innovation. During a career that includes executive roles at Takeda, Johnson & Johnson, Bristol Myers Squibb and Novartis, Keresty has been responsible for operations in more than 20 countries and led a $150M R&D affiliate developing novel therapies to treat and prevent Alzheimer’s disease.

In addition to the Aspen Technology board of directors, Keresty currently serves as an independent director for Commissioning Agents, Inc. an ESOP global engineering services firm, and has previously served on the board of Janssen Alzheimer Immunotherapy, the board of trustees for Clarkson University, Potsdam, NY and the board of trustees for the NJ Foundation for Aging. Keresty is currently the Takeda R&D chief operating officer.

Keresty holds BSc degrees in Chemical Engineering and Computer Science; an MS degree in Information Systems; an MBA in Operations Management; a PhD in Operations Management; and an MPH in Global Health Leadership.

“I am honored to join the board of directors for Aspen Technology. I look forward to bringing my industry knowledge and passion for operational excellence and quality assurance to the impressive accomplishments and insight of the current board members,” commented Georgia Keresty.

“We welcome Georgia Keresty to the Aspen Technology board, where her proven success in managing complex operations within the pharmaceutical industry will complement the expertise of the existing board,” commented Antonio Pietri, president, CEO and board member at Aspen Technology.

About Aspen Technology

Aspen Technology (AspenTech) is a leading software supplier for optimizing asset performance. Our products thrive in complex, industrial environments where it is critical to optimize the asset design, operation and maintenance lifecycle. AspenTech uniquely combines decades of process modelling expertise with big data machine learning. Our purpose-built software platform automates knowledge work and builds sustainable competitive advantage by delivering high returns over the entire asset lifecycle. As a result, companies in capital-intensive industries can maximize uptime and push the limits of performance, running their assets safer, greener, longer and faster. Visit AspenTech.com to find out more.

© 2019 Aspen Technology, Inc. AspenTech, the Aspen leaf logo and Aspen are trademarks of Aspen Technology, Inc. All rights reserved.